Saleemah Yasmeen Fahmi, MD
NPI 1922283506ActiveIndividual· Internal Medicine, Endocrinology, Diabetes & Metabolism· Dallas, TX
Internal Medicine, Endocrinology, Diabetes & Metabolism (MD) in Dallas, Texas, trained at New York University School of Medicine (class of 2001). Their prescriptions cost Medicare Part D more than their services did: $4,966,836 for 5,697 claims, against $131,295 paid for services in 2024. Amgen Inc. was the largest of 26 companies reporting payments in 2025, $300,107 in all, mostly speaking and faculty fees.
Overview
| NPI | 1922283506 |
|---|---|
| Status | Active |
| Entity type | Individual |
| Credential | MD |
| Sole proprietor | Yes |
| NPI issued | Jan 2, 2008 |
| Last updated in NPPES | Jan 19, 2012 |
Specialties and licenses
| Taxonomy | Code | License | State |
|---|---|---|---|
| Internal Medicine, Endocrinology, Diabetes & Metabolism Primary | 207RE0101X | M8648 | TX |
Exclusion screening
| List | Result | Details |
|---|---|---|
| HHS-OIG LEIE · Oct 9, 2026 | No match | Checked by NPI and by name + state |
| North Carolina Medicaid · Nov 10, 2026 | No match | — |
| New York OMIG · Nov 10, 2026 | No match | — |
| Ohio Medicaid · Nov 10, 2026 | No match | — |
| Pennsylvania Medicheck · Nov 10, 2026 | No match | — |
| Washington HCA · Nov 10, 2026 | No match | — |
Official OIG search · How matching works ·Bulk check a roster
Medicare
| Enrollment (PECOS) | Enrolled Practitioner - Endocrinology (TX) |
|---|---|
| Accepts assignment | Yes (participating) |
Medicare services in 2024
| Medicare patients | 269 |
|---|---|
| Services billed | 1,947 across 14 procedure codes |
| Paid by Medicare | $131,295 |
Part D prescriptions in 2024
| Prescriptions (claims) | 5,697 · 10,961 30-day fills |
|---|---|
| Patients | 592 |
| Total drug cost | $4,966,836 |
| Generic share | 35% of claims |
Education and affiliations
| Medical school | New York University School of Medicine |
|---|---|
| Graduation year | 2001 |
| Medicare specialty | Endocrinology |
| Secondary specialties | Internal Medicine |
| Telehealth | Offers telehealth |
Hospital affiliations
Industry payments (Open Payments)
- 2025$300,107 · 553 payments from 26 companies
- 2024$245,814 · 485 payments from 24 companies
Top paying companies in 2025
| Company | Amount | Payments |
|---|---|---|
| Amgen Inc. | $93,700 | 114 |
| Lilly USA, LLC | $76,558 | 166 |
| Corcept Therapeutics | $54,596 | 58 |
| Abbott Laboratories | $43,714 | 82 |
| Xeris Pharmaceuticals, Inc. | $24,209 | 51 |
What the 2025 payments were for
- Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program$180,494 · 144 payments
- Travel and Lodging$40,578 · 114 payments
- Compensation for serving as faculty or as a speaker for a medical education program$26,875 · 26 payments
- Honoraria$22,440 · 12 payments
- Consulting Fee$19,574 · 6 payments
- Food and Beverage$10,134 · 250 payments
- Education$12.25 · 1 payment
Receiving payments does not imply wrongdoing. What Open Payments covers ·original records
Other Internal Medicine, Endocrinology, Diabetes & Metabolism providers in Dallas
- 1538320072
- 1245696806
- 1619090222
- 1457861825
- 1306890736
- 1891718011
- 1518288596
- 1659301380
- 1518146935
- 1336350032
- 1932382249
- 1376288670
All Internal Medicine, Endocrinology, Diabetes & Metabolism providers in Texas →